Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Free to get started. No card charged today.
Browse 8,265 companies freeA deep investigation into Tempus AI's data collection, privacy violations, and surveillance practices. Founded 2015 in Chicago, Illinois.
Upgrade to SeekerPro for deep-dive reports on every company that touches your data. Members get breach timelines, violation histories, privacy risk scores, and executive contact data before anyone else.
Try SeekerPro →Tempus AI is a healthcare data analytics company that has built one of the largest libraries of clinical and molecular data in the world, processing genomic sequences, pathology images, and clinical records from over 100,000 cancer patients to develop AI-powered precision medicine tools. Founded by Groupon co-founder Eric Lefkofsky, Tempus went public in June 2024 at a valuation exceeding $6 billion, making it one of the largest healthcare AI IPOs in history. The company licenses its genomic and clinical datasets to pharmaceutical companies for drug development, clinical trial matching, and therapeutic research, creating a business model where cancer patients genomic data becomes a commercial asset. While Tempus argues this data sharing accelerates life-saving drug development, critics point out that patients rarely understand the full extent of how their genomic data is commercialized when they consent to genomic testing through their oncologist. Tempus partners with over 40% of academic medical centers in the United States and has processed genomic data that, unlike other health data, can identify individuals and their biological relatives with near certainty. The company also offers Tempus One, an AI clinical assistant that processes patient records to suggest treatment options, raising questions about algorithmic bias in cancer treatment recommendations and the liability framework when AI influences life-or-death medical decisions.
The following is a documented list of data points that Tempus AI collects from users, customers, and in some cases non-users. This data powers their business model, fuels targeted advertising, and in many cases is shared with or sold to third parties including government agencies.
Upgrade to SeekerPro for deep-dive reports on every company that touches your data. Members get breach timelines, violat...
Try SeekerPro →Run a free privacy and compliance scan on any website in 60 seconds. NexusBro checks cookie consent, hidden trackers, th...
Try NexusBro →Stop spending hours filing DSAR requests and opt-out forms manually. BliniBot automates data deletion requests, cookie c...
Try BliniBot →Below is a timeline of documented privacy violations, regulatory fines, lawsuits, and enforcement actions against Tempus AI. These events represent only the violations that became public. The true scope of data misuse at any major company is almost certainly larger than what regulators and journalists have uncovered.
Concerns raised about informed consent for genomic data commercialization
N/A (policy concern)
IPO prospectus reveals extent of pharma data licensing revenue
N/A (disclosure)
Patient advocates question re-identifiability of genomic data
Ongoing debate
You do not have to accept Tempus AI's data practices. These alternatives offer comparable functionality with significantly better privacy protections. Switching reduces the volume of personal data flowing into commercial surveillance systems and sends a market signal that privacy matters.
Run a free privacy and compliance scan on any website in 60 seconds. NexusBro checks cookie consent, hidden trackers, th...
Try NexusBro →Stop spending hours filing DSAR requests and opt-out forms manually. BliniBot automates data deletion requests, cookie c...
Try BliniBot →Build compliant marketing campaigns that convert without invasive tracking. ContentMation generates privacy-respecting f...
Try ContentMation →Start by understanding what data Tempus AI already has on you. Check your account settings, download your data archive if available, and review what permissions you have granted. Use OpenPublicHub to research the full scope of Tempus AI's data practices and compare them against industry standards.
Disable unnecessary data collection settings, revoke app permissions you do not actively need, and opt out of personalized advertising where possible. Review connected third-party apps and remove any that you no longer use. Every permission you revoke reduces your attack surface and limits the data available for profiling.
Under GDPR, CCPA, and other privacy laws, you have the right to request access to, correction of, and deletion of your personal data. File a Data Subject Access Request (DSAR) to see what Tempus AI holds about you. Use BliniBot to automate the process across multiple companies simultaneously.
The most effective protection is to stop using privacy-invasive services entirely. The alternatives listed above offer comparable functionality without the surveillance. Start with the service you use most frequently and work through the list. Every user who switches sends a market signal that privacy is a competitive advantage.
Privacy threats evolve constantly. Follow this expose and related reports on OpenPublicHub to stay updated on Tempus AI's practices. Share this page with friends and colleagues so they can protect themselves too. Collective action and informed consumers are the most powerful force for changing corporate behavior.
Tempus licenses clinical and genomic datasets to pharmaceutical companies for drug development and research purposes. While the company characterizes this as enabling precision medicine, patients whose genomic data is included in these datasets may not fully understand the commercial scope of how their data is used when they consent to genomic testing through their physician.
Yes. Unlike most health data, genomic data is inherently identifiable because your DNA sequence is unique. Tempus claims to de-identify data, but genomic researchers have demonstrated that genomic data can be re-identified using publicly available genealogy databases. Your genomic data can also implicate biological relatives.
Tempus One is an AI clinical assistant that analyzes patient records and suggests treatment options to oncologists. While the AI does not make final decisions, it influences physician recommendations in ways that may introduce algorithmic bias, particularly for underrepresented populations whose genomic data is less present in training datasets.
Upgrade to SeekerPro for deep-dive reports on every company that touches your data. Members get breach timelines, violat...
Try SeekerPro →Run a free privacy and compliance scan on any website in 60 seconds. NexusBro checks cookie consent, hidden trackers, th...
Try NexusBro →Stop spending hours filing DSAR requests and opt-out forms manually. BliniBot automates data deletion requests, cookie c...
Try BliniBot →Tools trusted by thousands of privacy-conscious professionals worldwide
No card charged today. Cancel anytime.
Want unlimited access? Explore SeekerPro